Related Experiment Videos
Nasal sarcoidosis with septal perforation
The Journal of Otolaryngology
|February 1, 1980
Summary
Systemic sarcoidosis presenting with nasal symptoms can be challenging to treat. An inhaled corticosteroid, beclomethasone dipropionate, effectively relieved nasal symptoms in a patient refractory to systemic treatments.
Area of Science:
- Otorhinolaryngology
- Pulmonology
- Dermatology
Background:
- Systemic sarcoidosis is a multisystem granulomatous disease.
- Nasal manifestations can be the initial presentation of sarcoidosis.
- Treatment of nasal sarcoidosis often involves corticosteroids.
Observation:
- A patient with systemic sarcoidosis presented with nasal symptoms.
- Nasal symptoms persisted despite septal reconstruction and systemic corticosteroid therapy.
- Anterior septal perforation developed during methylprednisolone treatment.
Findings:
- Beclomethasone dipropionate inhaler provided significant relief from nasal symptoms.
- Topical corticosteroid therapy may be effective for nasal sarcoidosis when systemic treatments fail.
- Nasal septal perforation is a potential complication of corticosteroid treatment in sarcoidosis.
Implications:
- Inhaled corticosteroids represent a viable therapeutic option for nasal sarcoidosis.
- Careful monitoring is necessary during systemic corticosteroid treatment for sarcoidosis.
- Early diagnosis and tailored treatment are crucial for managing sarcoidosis with nasal involvement.